Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.18 - $1.74 $14,242 - $21,001
12,070 New
12,070 $21,000
Q4 2021

Feb 14, 2022

SELL
$2.35 - $5.58 $52,999 - $125,845
-22,553 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.25 - $3.03 $50,744 - $68,335
22,553 New
22,553 $58,000
Q3 2019

Nov 14, 2019

SELL
$2.47 - $3.51 $43,738 - $62,155
-17,708 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$3.06 - $51.61 $54,186 - $913,909
17,708 New
17,708 $56,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.